Jussi Koivunen

Assistant Professor

Oulu University Hospital

Finland

Research Interests

Explore related searches

Professors in Finland

Contact this professor

LinkedIn

Google Scholar

About

Jussi Koivunen is an Assistant Professor at Oulu University Hospital in Finland. His research focuses on cancer treatment, particularly in the areas of lung cancer, breast cancer, and chemotherapy-related outcomes. Recent publications include studies on the effectiveness of EGFR tyrosine kinase inhibitors and decision support tools for chemotherapy prescribing. With a strong emphasis on real-world treatment outcomes and innovative approaches in oncology, he contributes to advancing cancer care and patient support strategies.

Articles (14)

Concomitant Use of Analgesics and EGFR TKIs in Lung Cancer Patients: Outcomes and Perspectives From a Finnish Retrospective Register–Based Study

Year:

2025

Development of a Comprehensive Decision Support Tool for Chemotherapy-Cycle Prescribing: Initial Usability Study

Year:

2025

Smartphone application versus written material for smoking reduction and cessation in individuals undergoing low-dose computed tomography (LDCT) screening for lung cancer

Year:

2024

Role of human epidermal growth factor receptor 3 in treatment resistance of anaplastic lymphoma kinase translocated non-small cell lung cancer

Year:

2023

Assessment of chemotherapy‐induced neurotoxicity using a point‐of‐care nerve conduction study device

Year:

2023

Treatment outcomes of non-small cell lung cancers treated with EGFR tyrosine kinase inhibitors: a real-world cohort study

Year:

2023

Association of Rare Immune-Related Adverse Events to Survival in Advanced Cancer Patients Treated with Immune Checkpoint Inhibitors: A Real-World Single-Center Cohort Study.

Year:

2022

Trends in treatment of non-small cell lung cancer in Finland 2014-2019.

Year:

2022

Immune cell profiles of metastatic HER2-positive breast cancer patients according to the sites of metastasis

Year:

2022

Isolated limb perfusion with melphalan as treatment for regionally advanced melanoma of the limbs: results of 60 patients treated in Finland during 2007-2018.

Year:

2021

Intracranial effect of osimertinib in relapsed <i>EGFR</i>-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study.

Year:

2021

Purchase of prophylactic topical corticosteroids is associated with improved survival in NSCLCs treated with EGFR TKI: real-world cohort study.

Year:

2021

Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial.

Year:

2021

Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients

Year:

2020

Collaborators (3)

Heidi Andersén

University of Tampere

FINLAND

Christine Jacob

Lecturer and Health-Tech Researcher

Fachhochschule Nordwestschweiz

SWITZERLAND

Martti Arffman

Finnish Institute for Health and Welfare

FINLAND

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI